arrow
A

Aleksandra Grela-Wojewoda

Maria Sklodowska-Curie National Research Institute of Oncology
H指数:11
被引数:359

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

REAL-WORLD OUTCOMES WITH PALBOCICLIB, RIBOCICLIB, AND ABEMACICLIB PLUS ENDOCRINE THERAPY IN HR+/HER2− ADVANCED BREAST CANCER: A MULTICENTER RETROSPECTIVE STUDY

真实世界研究中,PALBOCICLIB、RIBOCICLIB和ABEMACICLIB联合内分泌疗法在HR+/HER2−晚期乳腺癌中的疗效:一项多中心回顾性研究

2025-11-240
OAAI
Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland

纳武利尤单抗和伊匹木单抗在老年肾细胞癌患者中的有效性与安全性:来自波兰一项多中心观察性研究的结果

2025-08-230
OA
Validation of the EORTC information (QLQ-INFO25) and satisfaction with care (IN-PATSAT32) modules in the Polish cancer patient population

EORTC信息(QLQ-INFO25)和护理满意度(IN-PATSAT32)模块在波兰癌症患者人群中的验证

2025-02-130
OA
Prognostic significance of peripheral blood biomarkers in patients with advanced renal cell carcinoma treated with nivolumab and ipilimumab-a polish multicenter, observational study
2025-01-230
OAAI
Time from Final Oncologist Visit to Death and Palliative Systemic Treatment Use Near the End of Life in Heavily Pretreated Patients with Luminal Breast Cancer

在经过大量预处理的管腔乳腺癌患者中,从最终的肿瘤科医生就诊到死亡和姑息性全身治疗的时间接近生命的终点

2024-11-080
OAAI
Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort Study

Sacituzumab Govitecan用于三阴性乳腺癌患者的二线和后续姑息治疗: 一项波兰真实世界多中心队列研究

2024-09-270
OAAI
Cancer care for Ukrainian refugees during the first 6 weeks of 2022 Russian invasion-An experience of a cancer reference centre in Poland

在俄罗斯入侵2022年的前6周内为乌克兰难民提供癌症护理-波兰癌症参考中心的经验

2023-01-017
OAAI
Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience

Nivolumab和Ipilimumab联合免疫疗法治疗波兰转移性黑色素瘤的早期效果: 多中心经验

2022-10-103
OAAI
Adjuvant combined therapy with trastuzumab in patients with HER2-positive breast cancer and cardiac alterations: implications for optimal cardio-oncology care

HER2-positive乳腺癌和心脏改变患者的曲妥珠单抗辅助联合治疗: 对最佳心脏肿瘤护理的意义

2022-01-284
OA
Predictive value of quantitative HER2 and HER3 levels combined with downstream signaling markers in HER2-positive advanced breast cancer patients treated with lapatinib
2017-02-150
PRE